TMEM45A Antibody

SKU: orb357227

Description

This TMEM45A Antibody is an unconjugated polyclonal product. It tagets TMEM45A using a Recombinant Human Transmembrane protein 45A protein (171-217AA) as the immunogen. This antibody is suitable for ELISA, IF, IHC. Purification: >95%, Protein G purified.

Images & Validation

• Tested Applications: ELISA, IF, IHC
• Dilution range: IHC-P:1:20-200, IF:1:50-200
• Reactivity: Human

Key Properties

• Host: Rabbit
• Clonality: Polyclonal
• Isotype: IgG
• Immunogen: Recombinant Human Transmembrane protein 45A protein (171-217AA)
• Target: TMEM45A
• Purification: >95%, Protein G purified
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Form/Appearance: Liquid
• Buffer/Preservatives: Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol
• Disclaimer: For research use only

Alternative Names

anti-Transmembrane protein 45A antibody, anti-TMEM45A antibody, anti-DERP7 antibody, anti-DNAPTP4 antibody, anti-DNA polymerase-transactivated protein 4 antibody, anti-Dermal papilla-derived protein 7 antibody

Immunohistochemistry staining of human gastric cancer using TMEM45A antibody

Immunohistochemistry staining of human breast cancer using TMEM45A antibody

Immunofluorescent analysis of A2780 cells using TMEM45A antibody

Quick Database Links

Gene Symbol

TMEM45A

UniProt

Q9NWC5

References

Alföldi, Róbert et al. Single Cell Mass Cytometry of Non-Small Cell Lung Cancer Cells Reveals Complexity of In vivo And Three-Dimensional Models over the Petri-dish Cells, 8, (2019)

PubMed: 31527554

Kulmány, Ágnes E. et al. Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines Biomed Pharmacother, 140, 111728 (2021)

PubMed: 34020244

Neuperger, Patrícia et al. Analysis of the Single-Cell Heterogeneity of Adenocarcinoma Cell Lines and the Investigation of Intratumor Heterogeneity Reveals the Expression of Transmembrane Protein 45A (TMEM45A) in Lung Adenocarcinoma Cancer Patients Cancers (Basel), 14, 144 (2021)

PubMed: 35008313